BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37336339)

  • 1. Synthesis, in vitro cytotoxic activity and molecular docking study of androstene and estrone derivatives.
    Mistry S; Thakkar M; Singh AK; Patel D
    Steroids; 2023 Sep; 197():109259. PubMed ID: 37336339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition.
    El-Husseiny WM; El-Sayed MA; El-Azab AS; AlSaif NA; Alanazi MM; Abdel-Aziz AA
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):744-758. PubMed ID: 32183576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Evaluation of a New Series of Arylidene Indanones as Potential Anticancer Agents.
    Özdemir A; Gökbulut S; Sever B; Çiftçi GA; Altıntop MD
    Anticancer Agents Med Chem; 2018; 18(10):1394-1404. PubMed ID: 29210665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furo[2,3-d]pyrimidines as Mackinazolinone/Isaindigotone Analogs: Synthesis, Modification, Antitumor Activity, and Molecular Docking Study.
    Song B; Nie L; Bozorov K; Niu C; Kuryazov R; Akber Aisa H; Zhao J
    Chem Biodivers; 2023 Mar; 20(3):e202201059. PubMed ID: 36680784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
    Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
    Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, and anti-proliferative, Pim-1 kinase inhibitors and molecular docking of thiophenes derived from estrone.
    Mohareb RM; Samir EM; Halim PA
    Bioorg Chem; 2019 Mar; 83():402-413. PubMed ID: 30415021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
    El-Adl K; El-Helby AA; Sakr H; Elwan A
    Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Cytotoxic Analysis, and Molecular Docking Studies of Tetrazole Derivatives via N-Mannich Base Condensation as Potential Antimicrobials.
    Atef Hatamleh A; Al Farraj D; Salah Al-Saif S; Chidambaram S; Radhakrishnan S; Akbar I
    Drug Des Devel Ther; 2020; 14():4477-4492. PubMed ID: 33122891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antiproliferative agents bearing substituted thieno[2,3-d]pyrimidine scaffold as dual VEGFR-2 and BRAF kinases inhibitors and apoptosis inducers; design, synthesis and molecular docking.
    Hassan RA; Hamed MIA; Abdou AM; El-Dash Y
    Bioorg Chem; 2022 Aug; 125():105861. PubMed ID: 35569190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
    Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
    Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
    Alam MS; Lee DU
    Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and antitumor activities of some steroidal derivatives with side chain of 17-hydrazone aromatic heterocycle.
    Cui J; Liu L; Zhao D; Gan C; Huang X; Xiao Q; Qi B; Yang L; Huang Y
    Steroids; 2015 Mar; 95():32-8. PubMed ID: 25578734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 2-Substituted 4-Arylidene-5(4H)-oxazolones as Potential Cytotoxic Agents in the Presence of Lemon Juice as a Biocatalyst.
    Prasad MG; Lakshmi CV; Katari NK; Anand K; Pal M; Jonnalagadda SB
    Comb Chem High Throughput Screen; 2019; 22(9):625-634. PubMed ID: 31696809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors.
    El-Naggar AM; El-Hashash MA; Elkaeed EB
    Bioorg Chem; 2021 Mar; 108():104615. PubMed ID: 33484942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
    Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
    Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mono- and bis-pyrazolophthalazines: Design, synthesis, cytotoxic activity, DNA/HSA binding and molecular docking studies.
    Hamidinasab M; Ameri A; Hekmat A; Forootanfar H; Mortezazadeh T; Bodaghifard MA; Peytam F; Esmaeili R; Foroumadi A; Sharifzadeh M; Mobinikhaledi A; Khoobi M
    Bioorg Med Chem; 2021 Jan; 30():115944. PubMed ID: 33352388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antiproliferative evaluation and in silico studies of a novel steroidal spiro morpholinone.
    Cobos-Ontiveros LA; Romero-Hernández LL; Mastranzo-Sánchez EB; Colín-Lozano B; Puerta A; Padrón JM; Merino-Montiel P; Vega Baez JL; Montiel-Smith S
    Steroids; 2023 Apr; 192():109173. PubMed ID: 36621620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.
    Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB
    Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.